Insulet/$PODD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Insulet
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
Ticker
$PODD
Sector
Primary listing
Employees
5,400
Headquarters
Website
Insulet Metrics
BasicAdvanced
$9.7bn
26.30
$5.30
1.09
-
Price and volume
Market cap
$9.7bn
Beta
1.09
52-week high
$354.88
52-week low
$126.40
Average daily volume
1.6m
Financial strength
Current ratio
2.485
Quick ratio
1.51
Long term debt to equity
70.222
Total debt to equity
71.551
Interest coverage (TTM)
7.31%
Profitability
EBITDA (TTM)
614.4
Gross margin (TTM)
71.07%
Net profit margin (TTM)
12.29%
Operating margin (TTM)
16.89%
Effective tax rate (TTM)
24.14%
Revenue per employee (TTM)
$570,000
Management effectiveness
Return on assets (TTM)
9.71%
Return on equity (TTM)
26.02%
Valuation
Price to earnings (TTM)
26.299
Price to revenue (TTM)
3.194
Price to book
6.79
Price to tangible book (TTM)
7.69
Growth
Revenue change (TTM)
29.41%
Earnings per share change (TTM)
60.07%
3-year revenue growth (CAGR)
27.73%
10-year revenue growth (CAGR)
25.16%
3-year earnings per share growth (CAGR)
80.81%
10-year earnings per share growth (CAGR)
16.98%
What the Analysts think about Insulet
Analyst ratings (Buy, Hold, Sell) for Insulet stock.
Insulet Financial Performance
Revenues and expenses
Insulet Earnings Performance
Company profitability
Insulet News
AllArticlesVideos
PODD UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Insulet (PODD) Investors of Securities Class Action Lawsuit Deadline on August 31, 2026
Newsfile Corp·10 hours ago
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Insulet Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - PODD
Newsfile Corp·1 day ago
Bronstein, Gewirtz & Grossman LLC Urges Insulet Corporation Investors to Act: Class Action Filed Alleging Investor Harm
Newsfile Corp·1 day ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.